This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2019 Jul;6(7):e341-e342.

doi: 10.1016/S2352-3026(19)30092-4. Epub 2019 May 24.

Direct oral anticoagulants and obesity: one size fits all?

Paul L den Exter¹, Menno V Huisman²

Affiliations

Affiliations

¹ Department of Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, Postbus 9600, 2300 RC, The Netherlands. Electronic address: p.l.den_exter@lumc.nl.
² Department of Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, Postbus 9600, 2300 RC, The Netherlands.

PMID: 31133410
DOI: 10.1016/S2352-3026(19)30092-4

Comment

Direct oral anticoagulants and obesity: one size fits all?

Paul L den Exter et al. Lancet Haematol. 2019 Jul.

. 2019 Jul;6(7):e341-e342.

doi: 10.1016/S2352-3026(19)30092-4. Epub 2019 May 24.

Authors

Paul L den Exter¹, Menno V Huisman²

Affiliations

¹ Department of Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, Postbus 9600, 2300 RC, The Netherlands. Electronic address: p.l.den_exter@lumc.nl.
² Department of Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, Postbus 9600, 2300 RC, The Netherlands.

PMID: 31133410
DOI: 10.1016/S2352-3026(19)30092-4

No abstract available

PubMed Disclaimer

Comment on

Efficacy and safety of direct oral factor Xa inhibitors compared with warfarin in patients with morbid obesity: a single-centre, retrospective analysis of chart data.
Kushnir M, Choi Y, Eisenberg R, Rao D, Tolu S, Gao J, Mowrey W, Billett HH. Kushnir M, et al. Lancet Haematol. 2019 Jul;6(7):e359-e365. doi: 10.1016/S2352-3026(19)30086-9. Epub 2019 May 24. Lancet Haematol. 2019. PMID: 31133411

Similar articles

Direct oral factor Xa inhibitors in patients with morbid obesity - Author's reply.
Kushnir M. Kushnir M. Lancet Haematol. 2019 Sep;6(9):e447. doi: 10.1016/S2352-3026(19)30171-1. Lancet Haematol. 2019. PMID: 31471007 No abstract available.
Direct oral factor Xa inhibitors in patients with morbid obesity.
Summers KL, Mihm AE, Kenes MT. Summers KL, et al. Lancet Haematol. 2019 Sep;6(9):e446. doi: 10.1016/S2352-3026(19)30152-8. Lancet Haematol. 2019. PMID: 31471006 No abstract available.
Comparing Direct Oral Anticoagulants and Warfarin for Atrial Fibrillation, Venous Thromboembolism, and Mechanical Heart Valves.
Marcy TR, Truong T, Rai A. Marcy TR, et al. Consult Pharm. 2015 Nov;30(11):644-56. doi: 10.4140/TCP.n.2015.644. Consult Pharm. 2015. PMID: 26629800 Review.
Epistaxis in the setting of antithrombotic therapy: A comparison between factor Xa inhibitors, warfarin, and antiplatelet agents.
Glikson E, Chavkin U, Madgar O, Sagiv D, Nakache G, Yakirevitch A, Wolf M, Alon EE. Glikson E, et al. Laryngoscope. 2019 Jan;129(1):119-123. doi: 10.1002/lary.27400. Epub 2018 Oct 16. Laryngoscope. 2019. PMID: 30325496
New oral anticoagulants: which one should my patient use?
Weitz JI, Gross PL. Weitz JI, et al. Hematology Am Soc Hematol Educ Program. 2012;2012:536-40. doi: 10.1182/asheducation-2012.1.536. Hematology Am Soc Hematol Educ Program. 2012. PMID: 23233631 Review.

See all similar articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information